The EU Commission accepts commitments from pharmaceutical company to address excessive pricing (Aspen)

On 10 February 2021, the European Commission accepted commitments from Aspen under Article 9(1) of Regulation 1/2003, concluding a three year investigation into suspected excessive pricing…